Savion N, Farzame N
Thromb Res. 1986 Feb 15;41(4):459-70. doi: 10.1016/0049-3848(86)91691-9.
125I-labeled human antithrombin III (125I-AT III).protease complexes are specifically bound to both cultured human skin fibroblast (HSF) cells and adult bovine aortic endothelial (ABAE) cells; however, there is a significant difference in the rate and degree of metabolism of the complexes by these two cell types. HSF cells appear to internalize the complexes at a rate of about 2.5 pmole/1 X 10(6) cells/h and subsequently degrade them at a rate of 0.6 pmole/1 X 10(6) cells/h. ABAE cells internalize and degrade the complexes at rates approximately 100 and 30 times lower, respectively. Neither cell type interacts with free 125I-AT III but only with its combined form with either thrombin or trypsin. These data indicate the major role of HSF cells in the removal of AT III.protease complexes from extravascular spaces in the body, in contrast to the inert vascular surface with regard to AT III.protease complexes provided by the vascular endothelium.
125I标记的人抗凝血酶III(125I-AT III)-蛋白酶复合物能特异性结合培养的人皮肤成纤维细胞(HSF)和成年牛主动脉内皮细胞(ABAE);然而,这两种细胞类型对复合物的代谢速率和程度存在显著差异。HSF细胞似乎以约2.5皮摩尔/1×10⁶个细胞/小时的速率内化复合物,随后以0.6皮摩尔/1×10⁶个细胞/小时的速率降解它们。ABAE细胞内化和降解复合物的速率分别低约100倍和30倍。两种细胞类型均不与游离的125I-AT III相互作用,而仅与它与凝血酶或胰蛋白酶的结合形式相互作用。这些数据表明,与血管内皮提供的对AT III-蛋白酶复合物呈惰性的血管表面相比,HSF细胞在从体内血管外空间清除AT III-蛋白酶复合物中起主要作用。